William ... ... middle of paper ... ...atments by using immunotherapy as a treatment. Works Cited Cheever MA, Higano CS. PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clinical cancer research: an official journal of the American Association for Cancer Research. Lollini PL, Cavallo F, Nanni P, Forni G. Vaccines for tumour prevention.
Lamson, D.W. (2007). The roles of complementary medicine in oncology. Alternative Medicine Review, 12, 313-318. Urruticoechea, A., Alemany, R., Balart, J., Villanueva, A., Vinals, F., Capella, G. (2010). Recent advances in cancer therapy: an overview.
A comprehensive physical exam is a once-a-year routine screening being done for a general health check even if you feel healthy. It includes preventive health procedures such as mammogram, blood lipid profile, or a check for prostate cancer .The exams and screenings you need will depend on your age, family health history, and lifestyle choices including diet, physical activity level, smoking and drinking alcohol. Timely identification of health problems, which means no more excuses and to take an action to make an appointment with your doctor before it’s too late. Annual physical exams provide the early detection of serious illnesses, the prevention of expensive treatment, wellness maintenance and provide you a more complete picture of your overall health. Why does everyone a needs regular physical exam?
Journal of Biomedical Science, 17. doi:10.1186/1423-0127-17-21 Prica, A., Chan, K., & Cheung, M. (2012). Combined modality therapy versus chemotherapy as an induction regimen for primary central nervous system lymphoma: a decision analysis. British Journal Of Haematology, 158, 600-607. Urruticoechea, A., Alemany, R., Balart, J., Villanueva, A., Vinals, F., Capella, G. (2010). Recent advances in cancer therapy: an overview.
Retrieved from Clincial Trials: http://www.clinicaltrials.gov/ct2/about-studies/learn O'Neill, C. B., Atoria, C. L., O'Reilly, E. M., LaFemina, J., Henman, M. C., & Elkin, E. B. (2012). Costs and Trends in Pancreatic Cancer Treatment. Cancer, 5132. Stanford Medicine Cancer Institute.
Journal of the National Cancer Institute, 105(7), 452–8. doi:10.1093/jnci/djt007 6.Domcke, S., Sinha, R., Levine, D. a, Sander, C., & Schultz, N. (2013). Evaluating cell lines as tumour models by comparison of genomic profiles. Nature communications, 4, 2126. doi:10.1038/ncomms3126 7.Eva Kiesler, (http://www.mskcc.org, 2013) Do Cancer Cell Lines Really Resemble Tumors? Now Researchers Can Tell.
Stem cell transplant. Retrieved from http://www.mayoclinic.org/tests-procedures/stem-cell-transplant/basics/definition/prc-20013565 Mayo Clinic Staff. (2013). Disease and conditions leukemia. Retrieved from http://www.mayoclinic.org/diseases-conditions/leukemia/basics/causes/con-20024914 Zimmermann, C., Yuen, D., Mischitelle, A., Minden, M. D., Brandwein, J. M., Schimmer, A., Gagliese, L., Lo, C., Rydall, A., & Rodin, G. (2013).
A research study was conducted examining t... ... middle of paper ... ...ith their healthcare providers. References Gray, R. , Fitch, M. , & Greenberg, M. (1998). A comparison of physician and patient perspectives on unconventional cancer therapies. Psycho-oncology, 7(6), 445-452. Hillen, M. , de Haes, H. , & Smets, E. (2011).
Radhakrishnan, S. (2012). Hematologic malignancies: An opportunity to fill a gap in cancer surveillance. Cancer Causes and Control, 23(8), 1253-1264. doi:10.1007/s10552-012-0003-1 Trumbo, C. W., McComas, K. A., & Besley, J. C. (2008). Individual- and community-level effects on risk perception in cancer cluster investigations. Risk Analysis, 28(1), 161-178. doi:10.1111/j.1539-6924.2008.01007.x Yang, M. (2011).
Expert review of molecular diagnostics, 8(4), 405-415. National Cancer Institute. (2011). Human Papillomavirus (HPV) Vaccines. Retrieved from http://www.cancer.gov/cancertopics/factsheet/prevention/HPV-vaccine National Cancer Institute.